Drug
Dulanermin
Dulanermin: highest development phase Phase 1/2, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dulanermin NCT00400764 | Phase 1/2 | Non-Hodgkin's Lymphoma |
Latest
No recent events.
Follow Dulanermin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.